Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers
Clinical trial NCT02924155 · COMPLETED
Trial details
- NCT number
- NCT02924155
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-05
- Primary completion
- 2016-11-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.